163 related articles for article (PubMed ID: 18488139)
1. Multiple phospholipase activation by OX(1) orexin/hypocretin receptors.
Johansson L; Ekholm ME; Kukkonen JP
Cell Mol Life Sci; 2008 Jun; 65(12):1948-56. PubMed ID: 18488139
[TBL] [Abstract][Full Text] [Related]
2. OX1 orexin/hypocretin receptor activation of phospholipase D.
Jäntti MH; Putula J; Somerharju P; Frohman MA; Kukkonen JP
Br J Pharmacol; 2012 Feb; 165(4b):1109-23. PubMed ID: 21718304
[TBL] [Abstract][Full Text] [Related]
3. The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C.
Lund PE; Shariatmadari R; Uustare A; Detheux M; Parmentier M; Kukkonen JP; Akerman KE
J Biol Chem; 2000 Oct; 275(40):30806-12. PubMed ID: 10880509
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid release mediated by OX1 orexin receptors.
Turunen PM; Ekholm ME; Somerharju P; Kukkonen JP
Br J Pharmacol; 2010 Jan; 159(1):212-21. PubMed ID: 20002100
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin.
Kane JK; Tanaka H; Parker SL; Yanagisawa M; Li MD
Biochem Biophys Res Commun; 2000 Jun; 272(3):959-65. PubMed ID: 10860858
[TBL] [Abstract][Full Text] [Related]
6. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR.
Smart D; Jerman JC; Brough SJ; Rushton SL; Murdock PR; Jewitt F; Elshourbagy NA; Ellis CE; Middlemiss DN; Brown F
Br J Pharmacol; 1999 Sep; 128(1):1-3. PubMed ID: 10498827
[TBL] [Abstract][Full Text] [Related]
7. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors.
Smart D; Jerman JC; Brough SJ; Neville WA; Jewitt F; Porter RA
Br J Pharmacol; 2000 Apr; 129(7):1289-91. PubMed ID: 10742282
[TBL] [Abstract][Full Text] [Related]
8. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor.
Voisin T; Firar AE; Avondo V; Laburthe M
Endocrinology; 2006 Oct; 147(10):4977-84. PubMed ID: 16857748
[TBL] [Abstract][Full Text] [Related]
9. Lipid signaling cascades of orexin/hypocretin receptors.
Kukkonen JP
Biochimie; 2014 Jan; 96():158-65. PubMed ID: 23810911
[TBL] [Abstract][Full Text] [Related]
10. OX2 orexin/hypocretin receptor signal transduction in recombinant Chinese hamster ovary cells.
Kukkonen JP
Cell Signal; 2016 Feb; 28(2):51-60. PubMed ID: 26582739
[TBL] [Abstract][Full Text] [Related]
11. Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis.
Rouet-Benzineb P; Rouyer-Fessard C; Jarry A; Avondo V; Pouzet C; Yanagisawa M; Laboisse C; Laburthe M; Voisin T
J Biol Chem; 2004 Oct; 279(44):45875-86. PubMed ID: 15310763
[TBL] [Abstract][Full Text] [Related]
12. OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms.
Holmqvist T; Johansson L; Ostman M; Ammoun S; Akerman KE; Kukkonen JP
J Biol Chem; 2005 Feb; 280(8):6570-9. PubMed ID: 15611118
[TBL] [Abstract][Full Text] [Related]
13. Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B.
Asahi S; Egashira S; Matsuda M; Iwaasa H; Kanatani A; Ohkubo M; Ihara M; Morishima H
Bioorg Med Chem Lett; 2003 Jan; 13(1):111-3. PubMed ID: 12467628
[TBL] [Abstract][Full Text] [Related]
14. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
15. A role for PKD1 and PKD3 activation in modulation of calcium oscillations induced by orexin receptor 1 stimulation.
Peltonen HM; Akerman KE; Bart G
Biochim Biophys Acta; 2010 Oct; 1803(10):1206-12. PubMed ID: 20621130
[TBL] [Abstract][Full Text] [Related]
16. Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx.
Johansson L; Ekholm ME; Kukkonen JP
Br J Pharmacol; 2007 Jan; 150(1):97-104. PubMed ID: 17115071
[TBL] [Abstract][Full Text] [Related]
17. Sustained diacylglycerol accumulation resulting from prolonged G protein-coupled receptor agonist-induced phosphoinositide breakdown in hepatocytes.
Nilssen LS; Dajani O; Christoffersen T; Sandnes D
J Cell Biochem; 2005 Feb; 94(2):389-402. PubMed ID: 15526278
[TBL] [Abstract][Full Text] [Related]
18. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
19. Agonist ligand discrimination by the two orexin receptors depends on the expression system.
Putula J; Turunen PM; Jäntti MH; Ekholm ME; Kukkonen JP
Neurosci Lett; 2011 Apr; 494(1):57-60. PubMed ID: 21362456
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
Malherbe P; Borroni E; Gobbi L; Knust H; Nettekoven M; Pinard E; Roche O; Rogers-Evans M; Wettstein JG; Moreau JL
Br J Pharmacol; 2009 Apr; 156(8):1326-41. PubMed ID: 19751316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
